Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells
Carolyn M. Klinge, Kellianne M. Piell, Christine Schaner Tooley, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 88
Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis
Ling Deng, Qianqian Lei, Yu Wang, et al.
Oncotarget (2017) Vol. 8, Iss. 65, pp. 108712-108725
Open Access | Times Cited: 53
ExoBCD: a comprehensive database for exosomal biomarker discovery in breast cancer
Xuanyi Wang, Zixuan Chai, Guizhi Pan, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 3
Closed Access | Times Cited: 44
miR-539 acts as a tumor suppressor by targeting epidermal growth factor receptor in breast cancer
Jilong Guo, Guo-Hua Gong, Bin Zhang
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 46
Prognostic role of microRNAs in breast cancer: A systematic review
Eleni Zografos, Flora Zagouri, Despoina Kalapanida, et al.
Oncotarget (2019) Vol. 10, Iss. 67, pp. 7156-7178
Open Access | Times Cited: 41
Loss of Estrogen-Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer
Weijie Zhang, Mingming Wu, Qing-Yun Chong, et al.
Cancer Research (2018) Vol. 78, Iss. 17, pp. 4915-4928
Open Access | Times Cited: 28
miR-200c-3p Suppresses the Proliferative, Migratory, and Invasive Capacities of Nephroblastoma Cells via Targeting FRS2
Ting Li, Ping Zhao, Zhi Li, et al.
Biopreservation and Biobanking (2019) Vol. 17, Iss. 5, pp. 444-451
Closed Access | Times Cited: 23
Non-coding RNAs as Mediators of Tamoxifen Resistance in Breast Cancers
Mohd Farhan, Mohammad Aatif, Prasad Dandawate, et al.
Advances in experimental medicine and biology (2019), pp. 229-241
Closed Access | Times Cited: 23
Upregulation of lncRNA ZFAS1 promotes lung adenocarcinoma progression by sponging miR ‐1271‐5p and upregulating FRS2
Gang Fan, J. Jin, Feng Shen, et al.
Thoracic Cancer (2020) Vol. 11, Iss. 8, pp. 2178-2187
Open Access | Times Cited: 19
miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma
Şeref Buğra Tunçer, Özge Şükrüoğlu Erdoğan, Seda Kılıç, et al.
Journal of Ovarian Research (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Identification of miR‐145‐5p‐Centered Competing Endogenous RNA Network in Laryngeal Squamous Cell Carcinoma
Wei Gao, Yuliang Zhang, Min Niu, et al.
PROTEOMICS (2019) Vol. 19, Iss. 21-22
Closed Access | Times Cited: 19
From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells
Jéssica Fernanda Barazetti, Tayana Shultz Jucoski, Tamyres Mingorance Carvalho, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3688-3688
Open Access | Times Cited: 15
Connecting the Missing Dots: ncRNAs as Critical Regulators of Therapeutic Susceptibility in Breast Cancer
Elena-Georgiana Dobre, Sorina Dinescu, Marieta Costache
Cancers (2020) Vol. 12, Iss. 9, pp. 2698-2698
Open Access | Times Cited: 12
Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients
Feiling Feng, Xiaobing Wu, Xiaoliang Shi, et al.
International Journal of Clinical Oncology (2021) Vol. 26, Iss. 4, pp. 717-727
Closed Access | Times Cited: 11
Tephrosin Suppresses the Chemoresistance of Paclitaxel-Resistant Ovarian Cancer via Inhibition of FGFR1 Signaling Pathway
Hee Su Kim, Sowon Bae, Ye Jin Lim, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3155-3155
Open Access | Times Cited: 4
Glutamine synthetase regulates the immune microenvironment and cancer development through the inflammatory pathway
Do Thi Minh Xuan, Chung-Che Wu, Wei‐Jan Wang, et al.
International Journal of Medical Sciences (2022) Vol. 20, Iss. 1, pp. 35-49
Open Access | Times Cited: 7
miR-4653-3p overexpression is associated with a poor prognosis of pancreatic ductal adenocarcinoma via HIPK2 downregulation
Kenichi Hirabayashi, Masaki Miyazawa, Yumi Takanashi, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Molecular markers associated with the outcome of tamoxifen treatment in estrogen receptor-positive breast cancer patients: scoping review and in silico analysis
Maiquidieli Dal Berto, Giovana Tavares dos Santos, Aniúsca Vieira dos Santos, et al.
Discover Oncology (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Hsa_circ_0093741 competes with FRS2 for miR-562 binding sites to promote nephroblastoma progression.
Jiang Yong, Jun He, Feng Ning
PubMed (2023) Vol. 38, Iss. 5, pp. 559-570
Closed Access
miR-4653-3p overexpression is associated with a poor prognosis of pancreatic ductal adenocarcinoma via HIPK2 downregulation
Kenichi Hirabayashi, Masaki Miyazawa, Yumi Takanashi, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top